Health TrialsbyHealthPanel

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

ConditionHypertension
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Delaware

About this trial

The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

African American/Black

Diagnosed with Hypertension

Prescribed medication for hypertension

Disqualifiers

Cognitive limitations that limit the ability to provide informed consent

Pregnancy

Unable to speak or read English

Planning to relocate during the study period

Trial design

Design model

Parallel

Treatments tested in this trial

  • Web-Based Storytelling Intervention

    Behavioral

    The Web-based storytelling group will access stories and educational materials on the study website.

  • Group-Based Storytelling Plus Intervention

    Behavioral

    The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Usual CareNo intervention 0 interventions
Group B: Storytelling (Web-based Storytelling)Experimental treatment 1 intervention
Group C: Storytelling Plus (Group-based Storytelling)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Systolic and Diastolic Blood Pressure

Blood pressure will be measured three times using a manual blood pressure monitor.

Time frame
6 months
2

Adherence to Antihypertensive Medications (daily usage)

Medication adherence will be measured using Medication Electronic Measuring System (MEMS) caps

Time frame
6 months
3

Adherence to Antihypertensive Medications (self reported)

Medication adherence will be measure through participant self report Domains of Subjective Extent of Nonadherence scale.

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Delaware

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Source ClinicalTrials.gov
Apply now